genekey, a subsidiary company of salubris located in chengdu, china, is focused on research and development of biotechnologically innovative drugs, with r&d platforms for recombinant protein drugs, antibody-based drugs and gene therapy drugs. it possesses a complete industrial chain for innovative drugs including new molecule design, process development, quality research, clinical trials and industrial production.